Ionis Pharmaceuticals Inc (NASDAQ: IONS) stock closed at $57.49 on 9/2/25 after a major increase of 34.8%. Moreover, exceptionally high trading volume at 719% of normal accompanied the advance. The stock has been strong relative to the market over the last nine months and has risen 34.7% during the last week.
Current PriceTarget Research Rating
Ionis Pharmaceuticals has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Ionis Pharmaceuticals has a very low Appreciation Score of 6 but a good Power Rating of 81, with the Low Neutral Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment